Biostock intervjuar Idogens VD Anders Karlsson om kvartalsrapport Q4 samt företrädesemissionen - IPO.se
Correction: Idogen AB Interim report January–September 2019 - Idogen
Idogen Year end report 3 - Idogen
Stories: EIC-funded company Idogen starts trading on Nasdaq First North Growth Market | EIC Community
Idogen appoints Anders Karlsson as new CEO - Idogen
Joakim Söderström - Idogen
Idogen's cell technology successfully advanced to large-scale production - Idogen
Idogen files patent application for new tolerogenic cell therapy
Idogen AB (publ) Corp. Reg. No.
Idogen's Historical Milestones - Idogen
Idogen publishes Year-end report for 2020
Annual Report
Idogen AB (publ) Org nr
Idogen's Historical Milestones - Idogen
Trading Direkt analyserar bolagen på Spotlight 2019-06-19: Touchtech & Idogen - YouTube
Idogen's Historical Milestones - Idogen
Idogen's Historical Milestones - Idogen
Investors Home
PRESS RELEASE IDOGEN AB
Idogen AB (publ) kommenterar handelsstoppet den 25 april 2019 - Idogen
Annual Report
Idogen's Historical Milestones - Idogen
Idogen's IDO 8 granted orphan drug designation in the USA - Idogen
Idogen - Times Square - Idogen
